-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GSdujEa7KuQRXeB7oC6xYDDC74eN2raYR6t9geiE6n20balRYKDdyAI+eokxC9aO Gxjlu1+5/44lY5aEShW0oA== 0001209191-03-017651.txt : 20030818 0001209191-03-017651.hdr.sgml : 20030818 20030818164117 ACCESSION NUMBER: 0001209191-03-017651 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030814 FILED AS OF DATE: 20030818 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GEE EDWIN A CENTRAL INDEX KEY: 0001198760 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 03853524 BUSINESS ADDRESS: STREET 1: C/O BIOCRYST PHARMACEUTICALS, INC STREET 2: 2190 PKWY LAKE DRIVE CITY: BIRMINGHAM STATE: AL ZIP: 35244 BUSINESS PHONE: 2054444600 MAIL ADDRESS: STREET 1: C/O BIOCRYST PHARMACEUTICALS, INC STREET 2: 2190 PKWY LAKE DRIVE CITY: BIRMINGHAM STATE: AL ZIP: 35244 4 1 doc4.xml FORM 4 SUBMISSION X0201 42003-08-140 0000729922 OSI PHARMACEUTICALS INC OSIP 0001198760 GEE EDWIN A C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 1000Common Stock2003-08-144M050006.75A7996DCommon Stock2003-08-144S010032.1D7896DCommon Stock2003-08-144S050032.16D7396DCommon Stock2003-08-144S090032.25D6496DCommon Stock2003-08-144S0300032.29D3496DCommon Stock2003-08-144S010032.291D3396DCommon Stock2003-08-144S040032.27D2996DStock Option (Right to Buy)6.752003-08-144M050000D1999-03-252008-03-24Common Stock50005000DOne third of the stock option became exercisable one year after the date of grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date.Robert L. Van Nostrand by Power of Attorney2003-08-18 -----END PRIVACY-ENHANCED MESSAGE-----